⌘K
t
JPMorgan Chase & Co. notified Life Science REIT PLC on March 10, 2026, of a change in its major holdings. This notification reported that as of March 6, 2026, JPMorgan Chase & Co. held a total of 9.281787% of voting rights, equivalent to 32,486,291 votes, in the company.
| Date | 10 Mar 2026 |
| Time | 16:15:29 |
| Category | Holding(s) in company |
| ID | 1033W |
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BP5X4Q29
Issuer Name
LIFE SCIENCE REIT PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
JPMorgan Chase & Co.
City of registered office (if applicable)
Country of registered office (if applicable)
US
4. Details of the shareholder
|
Name |
City of registered office |
Country of registered office |
|
J.P. Morgan Securities PLC |
|
|
5. Date on which the threshold was crossed or reached
06-Mar-2026
6. Date on which Issuer notified
10-Mar-2026
7. Total positions of person(s) subject to the notification obligation
|
% of voting rights attached to shares (total of 8.A) |
% of voting rights through financial instruments (total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) |
Total number of voting rights held in issuer |
|
|
Resulting situation on the date on which threshold was crossed or reached |
9.008082 |
0.273705 |
9.281787 |
32486291 |
|
Position of previous notification (if applicable) |
8.930979 |
0.279400 |
9.210379 |
|
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
|
Class/Type of shares ISIN code(if possible) |
Number of direct voting rights (DTR5.1) |
Number of indirect voting rights (DTR5.2.1) |
% of direct voting rights (DTR5.1) |
% of indirect voting rights (DTR5.2.1) |
|
GB00BP5X4Q29 |
|
31528301 |
|
9.008082 |
|
Sub Total 8.A |
31528301 |
9.008082% |
||
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Number of voting rights that may be acquired if the instrument is exercised/converted |
% of voting rights |
|
|
|
|
|
|
|
Sub Total 8.B1 |
|
|
|
|
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
|
Type of financial instrument |
Expiration date |
Exercise/conversion period |
Physical or cash settlement |
Number of voting rights |
% of voting rights |
|
Cash-settled Equity Swap |
30/09/2026 |
30/09/2026 |
Cash |
955007 |
0.272853 |
|
Cash-settled Equity Swap |
16/11/2026 |
16/11/2026 |
Cash |
2983 |
0.000852 |
|
Sub Total 8.B2 |
|
957990 |
0.273705% |
||
9. Information in relation to the person subject to the notification obligation
2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)
|
Ultimate controlling person |
Name of controlled undertaking |
% of voting rights if it equals or is higher than the notifiable threshold |
% of voting rights through financial instruments if it equals or is higher than the notifiable threshold |
Total of both if it equals or is higher than the notifiable threshold |
|
JPMorgan Chase & Co. |
J.P. Morgan Securities PLC |
9.008082 |
|
9.281787% |
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Chain of controlled undertakings:
JPMorgan Chase & Co.
JPMorgan Chase Bank, National Association (100%)
J.P. Morgan International Finance Limited (100%)
J.P. Morgan Capital Holdings Limited (100%)
J.P. Morgan Securities PLC (100%)
12. Date of Completion
10-Mar-2026
13. Place Of Completion
London